TransMedics $TMDX poised for potential 60% growth if stock hits...
TransMedics Group, Inc. (NASDAQ: TMDX) stands at a critical juncture in 2025, with its stock price volatility and ambitious growth targets in the organ transplant technology sector drawing significant attention...